Found: 13
Select item for more details and to access through your institution.
Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2213, doi. 10.1093/jac/dkae216
- By:
- Publication type:
- Article
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad526
- By:
- Publication type:
- Article
Host-Pathogen Interaction in Invasive Salmonellosis.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 10, p. 1, doi. 10.1371/journal.ppat.1002933
- By:
- Publication type:
- Article
Human immunodeficiency virus Tat associates with a specific set of cellular RNAs.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 53, doi. 10.1186/1742-4690-11-53
- By:
- Publication type:
- Article
The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.
- Published in:
- Retrovirology, 2011, v. 8, n. 1, p. 31, doi. 10.1186/1742-4690-8-31
- By:
- Publication type:
- Article
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2339
- By:
- Publication type:
- Article
Calprotectin and Lactoferrin Faecal Levels in Patients with <i>Clostridium difficile</i> Infection (CDI): A Prospective Cohort Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0106118
- By:
- Publication type:
- Article
Isotopic Radiolabeling of the Antiretroviral Drug [ 18 F]Dolutegravir for Pharmacokinetic PET Imaging.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 587, doi. 10.3390/ph15050587
- By:
- Publication type:
- Article
Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 6, p. 1350, doi. 10.3390/v15061350
- By:
- Publication type:
- Article
Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145536
- By:
- Publication type:
- Article
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137834
- By:
- Publication type:
- Article